Inhibition of p38 enhances ERK inhibitor efficacy in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Ryan, Meagan B.
Bryant, Kirsten L.
Hayes, Tikvah K.
Kher, Swapnil
Wood, Kris C.
Samatar, Ahmed A.
Cox, Adrienne D.
Der, Channing J.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4660
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4660
引用
收藏
页数：3
相关论文
共 50 条
  • [31] p38α blocks brown adipose tissue thermogenesis through p38δ inhibition
    Matesanz, Nuria
    Nikolic, Ivana
    Leiva, Magdalena
    Pulgarin-Alfaro, Marta
    Santamans, Ayelen M.
    Bernardo, Edgar
    Mora, Alfonso
    Herrera-Melle, Leticia
    Rodriguez, Elena
    Beiroa, Daniel
    Caballero, Ainoa
    Martin-Garcia, Elena
    Acin-Perez, Rebeca
    Hernandez-Cosido, Lourdes
    Leiva-Vega, Luis
    Torres, Jorge L.
    Centeno, Francisco
    Nebreda, Angel R.
    Antonio Enriquez, Jose
    Nogueiras, Ruben
    Marcos, Miguel
    Sabio, Guadalupe
    PLOS BIOLOGY, 2018, 16 (07):
  • [32] The early autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal adenocarcinoma model
    Donohue, Elizabeth
    Thomas, Anitha
    Maurer, Norbert
    Manisali, Irina
    Zeisser-Labouebe, Magali
    Zisman, Natalia
    Anderson, Hilary J.
    Webb, Murray
    Bally, Marcel
    Roberge, Michel
    CANCER RESEARCH, 2013, 73
  • [33] Inhibition of BARD1-PLK1 axis enhances PARP inhibitor/platinum sensitivity in homologous repair proficient pancreatic ductal adenocarcinoma
    Coats, Carolyn
    Arkala, Anoohya
    Londin, Eric
    Nevler, Avinoam
    Brody, Jonathan R.
    Yeo, Charles J.
    Jain, Aditi
    CANCER RESEARCH, 2022, 82 (12)
  • [34] Inhibition of pro-inflammatory cytokine production by the dual p38/JNK2 inhibitor BIRB796 correlates with the inhibition of p38 signaling
    Gruenbaum, Lore M.
    Schwartz, Racheline
    Woska, Joseph R., Jr.
    DeLeon, Rodney P.
    Peet, Gregory W.
    Warren, Thomas C.
    Capolino, Alison
    Mara, Lisa
    Morelock, Maurice M.
    Shrutkowski, Anthony
    Jones, Jessi Wildeson
    Pargellis, Christopher A.
    BIOCHEMICAL PHARMACOLOGY, 2009, 77 (03) : 422 - 432
  • [35] Therapeutic benefit of targeting ERK in mutant KRAS pancreatic ductal adenocarcinoma
    Hayes, Tikvah K.
    CANCER RESEARCH, 2014, 74 (19)
  • [36] SQLE inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemotherapeutic agents in vitro
    Zhao, Fengyun
    Huang, Yanni
    Zhang, Yingheng
    Li, Xun
    Chen, Kaizhao
    Long, Yihao
    Li, Fugui
    Ma, Xiaodong
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (07) : 6613 - 6621
  • [37] Celecoxib enhances apoptosis of the liver cancer cells via regulating ERK/JNK/P38 pathway
    Jia, Zhe
    Zhang, Haitao
    Ma, Chao
    Li, Ning
    Wang, Menglong
    JOURNAL OF BUON, 2021, 26 (03): : 875 - 881
  • [38] Ornithine decarboxylase overexpression enhances ERK and p38 phosphorylation and matrix metalloproteinase-2 expression
    Nemoto, Takahiro
    Kubota, Shunichiro
    CELL BIOLOGY INTERNATIONAL, 2007, 31 (02) : 141 - 147
  • [39] SQLE inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemotherapeutic agents in vitro
    Fengyun Zhao
    Yanni Huang
    Yingheng Zhang
    Xun Li
    Kaizhao Chen
    Yihao Long
    Fugui Li
    Xiaodong Ma
    Molecular Biology Reports, 2022, 49 : 6613 - 6621
  • [40] Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same
    Sahu, Vishal
    Nigam, Lokesh
    Agnihotri, Vertica
    Gupta, Abhishek
    Shekhar, Shashank
    Subbarao, Naidu
    Bhaskar, Suntan
    Dey, Sharmistha
    CANCER RESEARCH AND TREATMENT, 2019, 51 (01): : 313 - 325
12345